LMO7: LIM Domain Only 7 - Gene and Protein Overview

Comprehensive biomedical resource for LMO7, including gene card, expression, mutations, and disease associations.

Gene Information Card

Symbol LMO7
Full Name LIM domain only 7
Gene Type protein-coding
Chromosomal Location 13q22.2
NCBI Gene ID 4008 ncbi.nlm.nih.gov/gene/4008
Ensembl ID ENSG00000106633
UniProt ID Q8WWI1
OMIM ID 604362
HGNC ID 6648
Aliases FBX20, FBXO20, KIAA0858, LMO-7

Description

LMO7 (LIM domain only 7) is a protein-coding gene located on chromosome 13q22.2. It encodes a protein containing LIM domains and a calponin homology domain, involved in cell adhesion, cytoskeletal organization, and transcriptional regulation. LMO7 interacts with actin and transcription factors, playing roles in muscle development and cancer progression. Alternative splicing yields multiple transcript variants.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer LMO7 overexpression promotes cell migration and invasion via actin cytoskeleton remodeling PMID: 23468909; COSMIC
Colorectal cancer LMO7 downregulation associated with poor prognosis and EMT activation PMID: 25636874; ClinVar
Emery-Dreifuss muscular dystrophy LMO7 mutations disrupt nuclear envelope integrity and muscle cell adhesion PMID: 17924336; OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.5 Medium
Skeletal muscle 10.3 Medium
Breast 6.8 Low
Colon 4.2 Low
Lung 3.1 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 15.2 High expression
HCT116 (colorectal cancer) 8.9 Moderate expression
HEK293 (embryonic kidney) 5.4 Low expression
A549 (lung cancer) 2.1 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412*) Nonsense <0.1% Loss of function; truncation
c.567G>A (p.Glu189Lys) Missense 0.2% Unknown; predicted damaging
c.890_891insA (p.Asn297Lysfs*5) Frameshift <0.1% Loss of function; premature stop
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations in LMO7 lead to truncated protein lacking functional LIM domains, impairing actin binding and nuclear localization.

Gain of Function (GOF)

Not well characterized; some missense variants may enhance protein stability or interaction with transcription factors, but evidence is limited.

Dominant Negative (DN)

No confirmed dominant-negative mutations reported; potential if mutant protein interferes with wild-type LMO7 in dimerization or scaffolding.

Gene Ontology (GO)

• actin binding • protein kinase binding
• LIM domain binding • cell adhesion
• cytoskeleton organization • transcription coregulator activity
• nucleus • cytoplasm
• cell junction

Pathways

• Actin cytoskeleton regulation
• Focal adhesion
• TGF-beta signaling
• Nuclear envelope organization

Protein Summary

LMO7 is a 170 kDa protein containing N-terminal calponin homology domain and C-terminal LIM domains. It localizes to the cytoplasm, nucleus, and cell junctions. LMO7 binds actin filaments and interacts with transcription factors such as ERM and YAP, modulating gene expression. It is implicated in cell adhesion, migration, and muscle integrity. Post-translational modifications include phosphorylation and ubiquitination.

Related Products

Product name Cat.No. Species Gene ID
LMO7 Knockout HEK293 Cell Line EDJ-KQ1134 Human 4008 Details Get a Quote
LMO7 Knockout HeLa Cell Line EDJ-KQ19002 Human 4008 Details Get a Quote
LMO7 Knockout A-549 Cell Line EDJ-KQ20346 Human 4008 Details Get a Quote
LMO7 Knockout HCT 116 Cell Line EDJ-KQ20347 Human 4008 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: